Literature DB >> 19074597

The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis.

Charlene D Fell1, Lyrica Xiaohong Liu, Caroline Motika, Ella A Kazerooni, Barry H Gross, William D Travis, Thomas V Colby, Susan Murray, Galen B Toews, Fernando J Martinez, Kevin R Flaherty.   

Abstract

RATIONALE: Idiopathic pulmonary fibrosis (IPF) is characterized by progressive dyspnea, impaired gas exchange, and ultimate mortality.
OBJECTIVES: To test the hypothesis that maximal oxygen uptake during cardiopulmonary exercise testing at baseline and with short-term longitudinal measures would predict mortality in patients with idiopathic pulmonary fibrosis.
METHODS: Data from 117 patients with IPF and longitudinal cardiopulmonary exercise tests were examined retrospectively. Survival was calculated from the date of the first cardiopulmonary exercise test.
MEASUREMENTS AND MAIN RESULTS: Patients with baseline maximal oxygen uptake less than 8.3 ml/kg/min had an increased risk of death (n = 8; hazard ratio, 3.24; 95% confidence interval, 1.10-9.56; P = 0.03) after adjusting for age, gender, smoking status, baseline forced vital capacity, and baseline diffusion capacity for carbon monoxide. We were unable to define a unit change in maximal oxygen uptake that predicted survival in our cohort.
CONCLUSIONS: We conclude that a threshold maximal oxygen uptake of 8.3 ml/kg/min during cardiopulmonary exercise testing at baseline adds prognostic information for patients with IPF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19074597      PMCID: PMC2648909          DOI: 10.1164/rccm.200802-241OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  32 in total

1.  Impairments and prognostic factors for survival in patients with idiopathic pulmonary fibrosis.

Authors:  K Miki; R Maekura; T Hiraga; Y Okuda; T Okamoto; A Hirotani; T Ogura
Journal:  Respir Med       Date:  2003-05       Impact factor: 3.415

2.  Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis.

Authors:  Harold R Collard; Talmadge E King; Becki Bucher Bartelson; Jason S Vourlekis; Marvin I Schwarz; Kevin K Brown
Journal:  Am J Respir Crit Care Med       Date:  2003-05-28       Impact factor: 21.405

Review 3.  ATS/ACCP Statement on cardiopulmonary exercise testing.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2003-01-15       Impact factor: 21.405

4.  Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation.

Authors:  N Mogulkoc; M H Brutsche; P W Bishop; S M Greaves; A W Horrocks; J J Egan
Journal:  Am J Respir Crit Care Med       Date:  2001-07-01       Impact factor: 21.405

5.  Clinical significance of histological classification of idiopathic interstitial pneumonia.

Authors:  K R Flaherty; G B Toews; W D Travis; T V Colby; E A Kazerooni; B H Gross; A Jain; R L Strawderman; R Paine; A Flint; J P Lynch; F J Martinez
Journal:  Eur Respir J       Date:  2002-02       Impact factor: 16.671

6.  Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.

Authors:  T E King; J A Tooze; M I Schwarz; K R Brown; R M Cherniack
Journal:  Am J Respir Crit Care Med       Date:  2001-10-01       Impact factor: 21.405

7.  Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality.

Authors:  T E King; M I Schwarz; K Brown; J A Tooze; T V Colby; J A Waldron; A Flint; W Thurlbeck; R M Cherniack
Journal:  Am J Respir Crit Care Med       Date:  2001-09-15       Impact factor: 21.405

8.  Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis.

Authors:  Kunio Hamada; Sonoko Nagai; Shigeru Tanaka; Tomohiro Handa; Michio Shigematsu; Taishi Nagao; Michiaki Mishima; Masanori Kitaichi; Takateru Izumi
Journal:  Chest       Date:  2007-02-22       Impact factor: 9.410

9.  Radiological versus histological diagnosis in UIP and NSIP: survival implications.

Authors:  K R Flaherty; E L Thwaite; E A Kazerooni; B H Gross; G B Toews; T V Colby; W D Travis; J A Mumford; S Murray; A Flint; J P Lynch; F J Martinez
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

10.  Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing.

Authors:  Roland Wensel; Christian F Opitz; Stefan D Anker; Jörg Winkler; Gert Höffken; Franz X Kleber; Rakesh Sharma; Manfred Hummel; Roland Hetzer; Ralf Ewert
Journal:  Circulation       Date:  2002-07-16       Impact factor: 29.690

View more
  23 in total

1.  Prognostic value of forced expiratory volume in 1 second/forced vital capacity in idiopathic pulmonary fibrosis.

Authors:  Osamu Nishiyama; Ryo Yamazaki; Akiko Sano; Toshiyuki Yamagata; Hiroyuki Sano; Takashi Iwanaga; Yuji Higashimoto; Hiroaki Kume; Yuji Tohda
Journal:  Chron Respir Dis       Date:  2015-09-15       Impact factor: 2.444

2.  Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis.

Authors:  J L Hook; S M Arcasoy; D Zemmel; M N Bartels; S M Kawut; D J Lederer
Journal:  Eur Respir J       Date:  2011-09-01       Impact factor: 16.671

3.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

4.  Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema.

Authors:  S L Schmidt; A M Nambiar; N Tayob; B Sundaram; M K Han; B H Gross; E A Kazerooni; A R Chughtai; A Lagstein; J L Myers; S Murray; G B Toews; F J Martinez; K R Flaherty
Journal:  Eur Respir J       Date:  2010-12-09       Impact factor: 16.671

5.  8-Foot-Up-and-Go Test is Associated with Hospitalizations and Mortality in Idiopathic Pulmonary Fibrosis: A Prospective Pilot Study.

Authors:  Baruch Vainshelboim; Mordechai Reuven Kramer; Jonathan Myers; Avraham Unterman; Shimon Izhakian; Jose Oliveira
Journal:  Lung       Date:  2019-01-02       Impact factor: 2.584

6.  MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study.

Authors:  Effrosyni D Manali; Panagiotis Lyberopoulos; Christina Triantafillidou; Likourgos F Kolilekas; Christina Sotiropoulou; Joseph Milic-Emili; Charis Roussos; Spyros A Papiris
Journal:  BMC Pulm Med       Date:  2010-05-28       Impact factor: 3.317

7.  Predicting pulmonary fibrosis disease course from past trends in pulmonary function.

Authors:  Shelley L Schmidt; Nabihah Tayob; Meilan K Han; Christopher Zappala; Dolly Kervitsky; Susan Murray; Athol U Wells; Kevin K Brown; Fernando J Martinez; Kevin R Flaherty
Journal:  Chest       Date:  2014-03-01       Impact factor: 9.410

8.  Exercise limitation in IPF patients: a randomized trial of pulmonary rehabilitation.

Authors:  Robert M Jackson; Orlando W Gómez-Marín; Carol F Ramos; Constanza M Sol; Meryl I Cohen; Ignacio A Gaunaurd; Lawrence P Cahalin; Diana D Cardenas
Journal:  Lung       Date:  2014-04-05       Impact factor: 2.584

9.  EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations.

Authors:  Marco Guazzi; Volker Adams; Viviane Conraads; Martin Halle; Alessandro Mezzani; Luc Vanhees; Ross Arena; Gerald F Fletcher; Daniel E Forman; Dalane W Kitzman; Carl J Lavie; Jonathan Myers
Journal:  Circulation       Date:  2012-09-05       Impact factor: 29.690

10.  Cardiopulmonary Exercise Testing Allows Discrimination Between Idiopathic Non-specific Interstitial Pneumonia and Idiopathic Pulmonary Fibrosis in Mild to Moderate Stages of the Disease.

Authors:  Lars Hagmeyer; Simon Herkenrath; Norbert Anduleit; Marcel Treml; Winfried Randerath
Journal:  Lung       Date:  2019-11-01       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.